Biodesix announces fourth quarter and fiscal year 2023 results and business highlights

Louisville, colo.--(business wire)---- $bdsx #patientsfirst--biodesix, inc. (nasdaq: bdsx), a leading diagnostic solutions and services company, today provided a corporate update and announced its financial and operating results for the fourth quarter and year ended december 31, 2023 (fiscal 2023). “i am exceptionally proud of the biodesix team and our record of accomplishments in 2023,” said scott hutton, ceo of biodesix. “we were focused on three goals: driving increased revenue through adoption of our lung diagnosti.
BDSX Ratings Summary
BDSX Quant Ranking